Mirum Pharmaceuticals (MIRM) Exchange Rate Effect (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Exchange Rate Effect of -$1.3 million for Q1 2026, down 220.57% year-over-year from $1.1 million in Q1 2025, and down 211.76% quarter-over-quarter from -$408000.0 in Q4 2025.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 220.57% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at $895000.0 (up 352.11% YoY), while the FY2025 annual figure was $3.2 million, up 348.42% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$1.3 million, down from -$408000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $2.2 million in Q2 2025, with the low at -$1.4 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$3000.0 (2022), against an average of $31294.1.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect plunged 1733.33% in 2022, then surged 6366.67% in 2023.
- Mirum Pharmaceuticals' Exchange Rate Effect stood at $85000.0 in 2022, then climbed by 27.06% to $108000.0 in 2023, then sank by 1376.85% to -$1.4 million in 2024, then jumped by 70.41% to -$408000.0 in 2025, then sank by 211.76% to -$1.3 million in 2026.
- Business Quant data shows MIRM's Exchange Rate Effect at -$1.3 million in Q1 2026, -$408000.0 in Q4 2025, and $349000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Mirum Pharmaceuticals | 6.40 Bn | 5.96 Bn | 145.90 Mn | -1.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.37 Mn |
| Mar 31, 2026 | -1.27 Mn |
| Dec 31, 2025 | -408,000.00 |
| Sep 30, 2025 | 349,000.00 |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | -1.38 Mn |
| Sep 30, 2024 | 88,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Mar 31, 2024 | 113,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Sep 30, 2023 | -315,000.00 |
| Jun 30, 2023 | -114,000.00 |
| Mar 31, 2023 | 188,000.00 |
| Dec 31, 2022 | 85,000.00 |
| Sep 30, 2022 | -21,000.00 |
| Jun 30, 2022 | -49,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Jun 30, 2021 | 3,000.00 |